Indies Pharma Jamaica Limited (JMSE:INDIES)
Jamaica · Delayed Price · Currency is JMD 2.990
-0.010 (-0.33%)
At close: Oct 24, 2025
Indies Pharma Jamaica Cash Flow Statement
Financials in millions JMD. Fiscal year is November - October.
Millions JMD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2016 - 2019 |
Net Income | 244.56 | 251.77 | 217.63 | 220.79 | 167.87 | 207.35 | Upgrade |
Depreciation & Amortization | 63.23 | 61.44 | 60.16 | 56.84 | 53.73 | 48.9 | Upgrade |
Loss (Gain) From Sale of Assets | 1.55 | - | -3.07 | -1.88 | -2.4 | - | Upgrade |
Other Operating Activities | 22.7 | 39.98 | 72.99 | 59.07 | 62.95 | 10.7 | Upgrade |
Change in Accounts Receivable | -5.68 | 8.59 | -103.5 | -5.32 | 60.12 | 71.38 | Upgrade |
Change in Inventory | 120.69 | -78.19 | 5.13 | 47.09 | -76.08 | 10.42 | Upgrade |
Change in Accounts Payable | 61.55 | -26.01 | 29.26 | 3.03 | -31.49 | 11.56 | Upgrade |
Change in Income Taxes | 30.71 | - | - | - | -0.14 | -0.12 | Upgrade |
Change in Other Net Operating Assets | -149.14 | -7.57 | 0.88 | -64.39 | 131.91 | -444.3 | Upgrade |
Operating Cash Flow | 390.17 | 250.01 | 279.47 | 315.22 | 366.48 | -84.11 | Upgrade |
Operating Cash Flow Growth | 107.54% | -10.54% | -11.34% | -13.99% | - | - | Upgrade |
Capital Expenditures | -45.51 | -8.88 | -14.02 | -26.37 | -40.72 | -25.41 | Upgrade |
Sale of Property, Plant & Equipment | -1.55 | - | 3.53 | 1.88 | 2.98 | 0.7 | Upgrade |
Cash Acquisitions | - | - | - | - | - | -0 | Upgrade |
Sale (Purchase) of Intangibles | -45.98 | -19.98 | -62.44 | -61.68 | -202.93 | -114.7 | Upgrade |
Investment in Securities | -5.3 | - | 63.14 | 67.31 | 0.75 | -147.5 | Upgrade |
Other Investing Activities | -4.29 | 1.62 | 1.46 | 0.95 | 4.84 | -114.31 | Upgrade |
Investing Cash Flow | -102.64 | -27.24 | -8.33 | -17.92 | -235.09 | -401.22 | Upgrade |
Short-Term Debt Issued | - | - | 0.06 | - | - | 799.58 | Upgrade |
Long-Term Debt Issued | - | - | - | 3.43 | 0.6 | 77.05 | Upgrade |
Total Debt Issued | 15.28 | - | 0.06 | 3.43 | 0.6 | 876.63 | Upgrade |
Short-Term Debt Repaid | - | -0.29 | - | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -41.76 | -46.35 | -48.16 | -46.63 | - | Upgrade |
Total Debt Repaid | -32.54 | -42.05 | -46.35 | -48.16 | -46.63 | - | Upgrade |
Net Debt Issued (Repaid) | -17.26 | -42.05 | -46.29 | -44.73 | -46.03 | 876.63 | Upgrade |
Common Dividends Paid | -179.89 | -146.58 | -150.98 | -150.58 | -146.58 | -186.56 | Upgrade |
Other Financing Activities | -66.69 | -63.8 | -56.35 | -56.2 | -61.37 | -9.19 | Upgrade |
Financing Cash Flow | -263.85 | -252.42 | -253.62 | -251.5 | -253.99 | 680.89 | Upgrade |
Foreign Exchange Rate Adjustments | - | - | 0.45 | 0.1 | - | - | Upgrade |
Net Cash Flow | 29.69 | -29.65 | 17.98 | 45.89 | -122.59 | 195.56 | Upgrade |
Free Cash Flow | 344.66 | 241.13 | 265.45 | 288.85 | 325.76 | -109.52 | Upgrade |
Free Cash Flow Growth | 86.70% | -9.16% | -8.10% | -11.33% | - | - | Upgrade |
Free Cash Flow Margin | 30.03% | 20.80% | 25.15% | 30.82% | 38.47% | -14.30% | Upgrade |
Free Cash Flow Per Share | 0.26 | 0.18 | 0.20 | 0.22 | 0.24 | -0.08 | Upgrade |
Cash Interest Paid | 66.69 | 63.8 | 56.35 | 56.2 | 61.37 | 9.19 | Upgrade |
Cash Income Tax Paid | 22.16 | 22.16 | -7.87 | 0.32 | - | - | Upgrade |
Levered Free Cash Flow | 258.73 | 48.68 | 73.53 | 111.44 | -74.56 | 120.05 | Upgrade |
Unlevered Free Cash Flow | 300.58 | 88.97 | 115.27 | 149.24 | -31.46 | 126.16 | Upgrade |
Change in Working Capital | 58.12 | -103.18 | -68.24 | -19.6 | 84.32 | -351.06 | Upgrade |
Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.